Narmada Gelatines Ltd
Incorporated in 1969, Narmada Gelatines Ltd manufactures and sells Gelatine and Ossein[1]
- Market Cap ₹ 281 Cr.
- Current Price ₹ 464
- High / Low ₹ 545 / 330
- Stock P/E 7.60
- Book Value ₹ 250
- Dividend Yield 2.37 %
- ROCE 29.5 %
- ROE 23.7 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|
| 189 | 215 | 233 | |
| Sales growth | +14% | +20% | |
| 164 | 174 | 186 | |
| Operating Profit | 25 | 41 | 48 |
| OPM % | 13% | 19% | 20% |
| 2 | 4 | 4 | |
| Interest | 1 | 1 | 1 |
| Depreciation | 2 | 3 | 3 |
| Profit before tax | 24 | 41 | 48 |
| Tax % | 24% | 24% | |
| 18 | 31 | 37 | |
| EPS in Rs | 29.80 | 52.05 | 61.10 |
| Dividend Payout % | 34% | 21% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 20% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 58% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 21% |
| 3 Years: | 2% |
| 1 Year: | 25% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 24% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | Mar 2026 | Sep 2026 | |
|---|---|---|---|
| Equity Capital | 6 | 6 | 6 |
| Reserves | 114 | 139 | 145 |
| 13 | 8 | 5 | |
| 27 | 26 | 24 | |
| Total Liabilities | 160 | 179 | 181 |
| 33 | 41 | 45 | |
| CWIP | 7 | 6 | 7 |
| Investments | 42 | 45 | 41 |
| 78 | 87 | 87 | |
| Total Assets | 160 | 179 | 181 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | Mar 2026 | |
|---|---|---|
| 16 | 25 | |
| -29 | -13 | |
| 5 | -12 | |
| Net Cash Flow | -7 | -0 |
| Free Cash Flow | 1 | 15 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 88% | 79% |
Ratios
Consolidated / View Standalone
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Debtor Days | 48 | 49 |
| Inventory Days | 155 | 156 |
| Days Payable | 57 | 39 |
| Cash Conversion Cycle | 146 | 166 |
| Working Capital Days | 88 | 97 |
| ROCE % | 30% |
Insights
In beta| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| DCP share of net sales % ・Standalone data |
|
|||||||||
| Gelatine share of net sales % ・Standalone data |
||||||||||
| Export share of net sales % ・Standalone data |
||||||||||
| Top 10 customers share of TOI % ・Standalone data |
||||||||||
| DCP sales volume growth % YoY ・Standalone data |
||||||||||
| Gelatine sales volume growth % YoY ・Standalone data |
||||||||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
- Newspaper Publication of Un-audited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended 30th September, 2026
-
Un-Audited Financial Result For The Quarter And Half-Year Ended 30Th September 2026
- Board approved unaudited standalone and consolidated results for quarter and half year ended 30 September 2026.
-
Board Meeting Outcome for Un-Audited Financial Result For The Quarter And Half-Year Ended 30Th September 2026
- Board approved unaudited Q2 and half-year FY2026 results on November 12, 2026.
-
Board Meeting Intimation for For Financial Results For The Quarter And Half Year Ended September 30, 2026
- Board to meet on 12 Nov 2026 to approve Q2 and half-year results; trading window closes till 14 Nov.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Regulation 74(5) certificate received from RTA for quarter ended September 30, 2026.
Annual reports
-
Annual Report 2026
from bse
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
-
Annual Report 2021
from bse
-
Annual Report 2020
from bse
-
Annual Report 2019
from bse
-
Annual Report 2018
from bse
-
Annual Report 2017
from bse
-
Annual Report 2016
from bse
-
Annual Report 2015
from bse
-
Annual Report 2014
from bse
-
Annual Report 2013
from bse
-
Annual Report 2012
from bse
Business Overview:[1]
Company is engaged in the manufacture
of ossein and gelatin. It is located at Jabalpur
and has access to its main and essential
inputs of crushed bones, acid, lime and
water